期刊文献+

降钙素原与APACHEⅡ评分对急性胰腺炎病情严重程度及预后的评估价值 被引量:24

Clinical value of Procalcitonin and APACHE Ⅱ in the Evaluation of Severity and Prognosis of Patients with Acute Pancreatitis
原文传递
导出
摘要 目的:探讨血清降钙素原(PCT)与急性生理学与慢性健康状况评分(APACHEⅡ)对急性胰腺炎(AP)患者病情严重程度及预后的评估价值。方法:选取本院2012年5月.2015年5月收治的急性胰腺炎患者280例为研究对象。根据急性胰腺炎患者病情严重程度将其分为低危组(83例)、中危组(102例)和高危组(95例);按患者临床结局将其分为存活组(248例)及死亡组(32例),采用酶联免疫吸附法(ELISA)检测各组血清PCT水平同时记录APACHEⅡ评分情况,分别比较PCT水平的差异以及与APACHEⅡ评分的相关性,评价血清PCT及APACHEⅡ评分对急性胰腺炎患者病情严重程度及预后的评估价值。结果:低危组、中危组及高危组间血清PCT水平和APACHEⅡ评分的差异具有统计学意义(P〈0.05)。其中,高危组血清PCT水平和APACHEⅡ评分最高,中危组次之,低危组最低(P〈0.05);死亡组PCT水平及APACHEⅡ评分显著高于存活组(P〈0.05)。相关性分析显示血清PCT水平与APACHEⅡ评分呈正相关(r=0.64,P〈0.01)。以PCT〉2.13ng/mL为评估急性胰腺炎患者预后不佳界限时,其敏感性和特异性分别79.2%和91.3%;以APACHEⅡ评分〉18.1分为评估急性胰腺炎患者预后不佳界限时,其敏感性和特异性分别为82.7%和90.1%;两者指标串联评估敏感性及特异性分别为86.1%和92.9%,ROC曲线下面积为0.921(95%C10.824-0.938)。结论:急性胰腺炎患者血清PCT水平和APACHEⅡ评分具有较好的相关性,血清PCT水平越高,APACHEⅡ评分越高,患者病情越严重及预后也越差.二者联合可作为预测急性胰腺炎患者病情严重程度及预后的敏感指标,具有较好的临床应用价值。 Objoetive: To investigate the clinical value of serum procalcitonin (PCT) level and Acute Physiology and Chronic Health Evaluation (APACHE Ⅱ) in the evaluation of severity and prognosis of patients with acute pancreatitis (AP). Methods: A total of 280 patients with acute pancreatitis in our hospital from May 2012 to May 2015 were enrolled in the study. According to the severity of the disease, these patients were divided into the low-risk group (83 cases), moderate-risk group (102 cases) and high-risk group (95 cases). According to clinical outcome, these patients were divided into the survival group (248 cases) and death group (32 cases). The serum level of PCT were measured by enzyme linked immunosorbent assay (ELISA), and APACHE II score was analyzed. The differences of serum PCT levels and APACHE Ⅱ scores were compared and its correlation with APACHE II score were analyzed, and their correlation with the severity and the prognosis of acute pancreatitis were also assessed. Results: The difference in serum PCT levels and APACHE II scores among low-risk group, moderate-risk group and high-risk group was statistically significant, in which high-risk group was the highest, followed by moderate-risk group, low-risk group was the lowest (P〈0.05); Compared the survival group, the death group had higher serum PCT levels and APACHE Ⅱ score (P〈0.05). The PCT level and APACHE Ⅱ score were positive correlated (r=0. 64, P〈0.01). With PCT〉2.13 ng/mL considered as the boundary for poor prognosis of acute pancreatitis, the sensitivity was 79.2 %, the specificity was 91.3 %; With APACHE Ⅱ score〉 18.1 considered as the boundary for poor prognosis of acute pancreatitis, the sensitivity was 82.7 %, the specificity was 90.1%; The AUC was 0.921 (95 % CI 0.824-0.938), and the sensitivity was 86.1%, specificity was 92.9 % when the two cutoffvalues were both achieved. Conclusions: The serum PCT levels and APACHE Ⅱ score showed good correlation in acute pancreatitis; When the serum PCT level was higher, APACHE Ⅱ score was higher, and the prognosis was worse. Combination of seruna PCT level and APACHE Ⅱ score could be used as effective predictors for evaluating the severity and prognosis of AP.
出处 《现代生物医学进展》 CAS 2016年第28期5539-5542,共4页 Progress in Modern Biomedicine
基金 国家自然科学基金项目(81300197)
关键词 降钙素原 急性生理学与慢性健康状况评分 急性胰腺炎 预后 Procalcitonin Acute Physiology and Chronic Health Evaluation score Acute pancreatitis Prognosis
  • 相关文献

参考文献6

二级参考文献75

  • 1Marja-Leena Kylnp,Heikki Repo,Pauli Antero Puolakkainen.Inflammation and immunosuppression in severe acute pancreatitis[J].World Journal of Gastroenterology,2010,16(23):2867-2872. 被引量:101
  • 2Ji Young Park,Tae Joo Jeon,Tae Hwan Ha,Jin Tae Hwang,Dong Hyun Sinn,Tae-Hoon Oh,Won Chang Shin,Won-Choong.Bedside index for severity in acute pancreatitis:comparison with other scoring systems in predicting severity and organ failure[J].Hepatobiliary & Pancreatic Diseases International,2013,12(6):645-650. 被引量:37
  • 3费军,余洪俊,周健,黄显凯,梁华平,蒋耀光.多发伤患者血清降钙素原的变化[J].中华创伤杂志,2005,21(10):725-728. 被引量:10
  • 4Wanner G A, Keel M, Steckholzer U,et al. Relationship be- tween procalcitonin plasma levels and severity of injury, sep- sis, organ failure, and mortality in injured patients [ J ]. Crit Care Med, 2000,28 (4) :950-957.
  • 5Bone R C, Balk R A, Cerra F B ,et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992 [ J]. Chest, 2009, 136 (5 Sup- pl) : e28.
  • 6Indino P, Lemarchand P, Bady P, et al. Prospective study on procalcitonin and other systemic infection markers in pa- tients with leukocytosis[ J ]. Int J Infect Dis, 2008,12 (3) : 319-324.
  • 7Christ-Crain M, Mtiller B. Procalcitonin in bacterial infec tions-hype, hope, more or less? [ J ]. Swiss Med Wkly 2005,135 ( 31-32 ) :451-460.
  • 8Tsantes A, Tsangaris I, Kopterides P, et al. The role of pro- calcitonin and IL-6 in discriminating between septic and non- septic causes of ALI/ARDS: a prospective observational study [ J ]. Clin Chem Lab Med, 2013,51 ( 1 ) : 1-8.
  • 9Schroder J, Staubach K H, Zabel P, et al. Procalcitonin as a marker of severity in septic shock [ J ]. Langenbecks Arch Surg, 1999,384( 1 ) :33-38.
  • 10Bloos F, Marshall J C, Dellinger R P, et al. Multinational, observational study of proealeitonin in ICU patients with pneumonia requiring mechanical ventilation: a multieenter observational study [ J ]. Crit Care, 2011,15 (2) : R88.

共引文献87

同被引文献241

引证文献24

二级引证文献160

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部